Anti-diabetic medication

Drugs used in diabetes treat diabetes mellitus by lowering the glucose level in the blood. With the exceptions of insulinexenatideliraglutide and pramlintide, all are administered orally and are thus also called oral hypoglycemic agents or oral antihyperglycemic agents. There are different classes of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, as well as other factors.

Diabetes mellitus type 1 is a disease caused by the lack of insulin. Insulin must be used in type 1, which must be injected.

Diabetes mellitus type 2 is a disease of insulin resistance by cells. Type 2 diabetes mellitus is the most common type of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.

Several groups of drugs, mostly given by mouth, are effective in type 2, often in combination. The therapeutic combination in type 2 may include insulin, not necessarily because oral agents have failed completely, but in search of a desired combination of effects. The great advantage of injected insulin in type 2 is that a well-educated patient can adjust the dose, or even take additional doses, when blood glucose levels measured by the patient, usually with a simple meter, as needed by the measured amount of sugar in the blood.


Insulin is usually given subcutaneously, either by injections or by an insulin pump. Research of other routes of administration is underway. In acute-care settings, insulin may also be given intravenously. Insulins are typically characterized by the rate at which they are metabolized by the body, yielding different peak times and durations of action.[1] Faster-acting insulins peak quickly and are subsequently metabolized, while longer-acting insulins tend to have extended peak times and remain active in the body for more significant periods.[2]

Examples of rapid acting insulins (peak time at ~1 hour) include:

  • Insulin lispro (Humalog)
  • Insulin aspart (Novolog)
  • Insulin glulisine (Apidra)

Examples of short acting insulins (peak time between 2-4 hours) include:

  • Regular insulin (Humulin R, Novolin R)
  • Prompt insulin zinc (Semilente)

Examples of intermediate acting insulins (peak time between 4-10 hours) include:

  • Isophane insulin, neutral protamine Hagedorn (NPH) (Humulin N, Novolin N)
  • Insulin zinc (Lente)

Examples of long acting insulins (duration ~24 hours, often with no peak) include:

  • Extended insulin zinc insulin (Ultralente)
  • Insulin glargine (Lantus)
  • Insulin detemir (Levemir)
  • Insulin degludec (Tresiba)

Insulin degludec is sometimes classed separately as an “ultra-long” acting insulin due to its duration of action of approximately 42 hours, compared with 24 hours for most other long acting insulin preparations.[2]

Most anti-diabetic agents are contraindicated in pregnancy, in which insulin is preferred…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

WhatsApp WhatsApp Us for Payments!